EG20187A - Process for preparing etoposide 4- phosphate diethanolate - Google Patents

Process for preparing etoposide 4- phosphate diethanolate

Info

Publication number
EG20187A
EG20187A EG56692A EG56692A EG20187A EG 20187 A EG20187 A EG 20187A EG 56692 A EG56692 A EG 56692A EG 56692 A EG56692 A EG 56692A EG 20187 A EG20187 A EG 20187A
Authority
EG
Egypt
Prior art keywords
etoposide
phosphate diethanolate
phosphate
preparing etoposide
preparing
Prior art date
Application number
EG56692A
Other languages
English (en)
Inventor
Denis Favreau
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of EG20187A publication Critical patent/EG20187A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
EG56692A 1991-10-08 1992-09-26 Process for preparing etoposide 4- phosphate diethanolate EG20187A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/773,056 US5648474A (en) 1991-10-08 1991-10-08 Crystalline etoposide 4'-phosphate diethanolate

Publications (1)

Publication Number Publication Date
EG20187A true EG20187A (en) 1997-09-30

Family

ID=25097069

Family Applications (1)

Application Number Title Priority Date Filing Date
EG56692A EG20187A (en) 1991-10-08 1992-09-26 Process for preparing etoposide 4- phosphate diethanolate

Country Status (27)

Country Link
US (1) US5648474A (xx)
EP (1) EP0537555B1 (xx)
JP (1) JP3205816B2 (xx)
KR (1) KR100243981B1 (xx)
CN (1) CN1030610C (xx)
AT (1) ATE156832T1 (xx)
AU (1) AU650572B2 (xx)
CA (1) CA2079581C (xx)
CZ (1) CZ283735B6 (xx)
DE (1) DE69221573T2 (xx)
DK (1) DK0537555T3 (xx)
EG (1) EG20187A (xx)
ES (1) ES2109970T3 (xx)
FI (1) FI105034B (xx)
GR (1) GR3025176T3 (xx)
HU (2) HU213606B (xx)
IL (1) IL103262A (xx)
MX (1) MX9205777A (xx)
MY (1) MY108969A (xx)
NO (1) NO178342C (xx)
NZ (1) NZ244521A (xx)
PH (1) PH31666A (xx)
PL (1) PL168332B1 (xx)
RU (1) RU2042686C1 (xx)
SK (1) SK298692A3 (xx)
TW (1) TW239863B (xx)
ZA (1) ZA926903B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US4914222A (en) * 1983-08-29 1990-04-03 Merck & Co., Inc. Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
EP0369369B1 (en) * 1988-11-16 1994-01-26 Nippon Kayaku Kabushiki Kaisha Dihydrate crystals of etoposide-2-dimethylamino compound hydrochloride and a process for production thereof
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides

Also Published As

Publication number Publication date
ZA926903B (en) 1993-05-03
ATE156832T1 (de) 1997-08-15
HU9203119D0 (en) 1992-12-28
IL103262A0 (en) 1993-02-21
AU2530192A (en) 1993-04-22
CA2079581C (en) 2002-11-12
HUT62309A (en) 1993-04-28
AU650572B2 (en) 1994-06-23
EP0537555A1 (en) 1993-04-21
MY108969A (en) 1996-11-30
MX9205777A (es) 1993-04-01
FI924359A (fi) 1993-04-09
HU213606B (en) 1997-08-28
US5648474A (en) 1997-07-15
IL103262A (en) 1997-06-10
PL296078A1 (en) 1993-04-19
PL168332B1 (pl) 1996-02-29
DK0537555T3 (da) 1998-01-26
NZ244521A (en) 1994-02-25
JPH05194575A (ja) 1993-08-03
CN1071432A (zh) 1993-04-28
EP0537555B1 (en) 1997-08-13
FI105034B (fi) 2000-05-31
ES2109970T3 (es) 1998-02-01
NO178342B (no) 1995-11-27
JP3205816B2 (ja) 2001-09-04
PH31666A (en) 1999-01-12
KR100243981B1 (ko) 2000-02-01
FI924359A0 (fi) 1992-09-29
NO923754L (no) 1993-04-13
CA2079581A1 (en) 1993-04-09
TW239863B (xx) 1995-02-01
HU211672A9 (en) 1995-12-28
NO178342C (no) 1996-03-06
SK278935B6 (sk) 1998-04-08
KR930007968A (ko) 1993-05-20
RU2042686C1 (ru) 1995-08-27
DE69221573T2 (de) 1998-02-26
CZ298692A3 (en) 1993-04-14
CN1030610C (zh) 1996-01-03
SK298692A3 (en) 1998-04-08
GR3025176T3 (en) 1998-02-27
NO923754D0 (no) 1992-09-28
CZ283735B6 (cs) 1998-06-17
DE69221573D1 (de) 1997-09-18

Similar Documents

Publication Publication Date Title
KR960004869B1 (en) Process for preparing 1,1,12-tetrafluoro-ethane
AU1077992A (en) Process for preparing 1,3-dioxols
ZA938576B (en) Process for preparing 1,3-difluorobenzene
EG20187A (en) Process for preparing etoposide 4- phosphate diethanolate
EP0480465A3 (en) Process for preparing 5-aroyl-2,3-dihydro-1h-pyrrolizine-1,1,-dicarboxylates
AU630007B2 (en) Process for producing des(64,65)-proinsulin
EP0538686A3 (en) Process for the preparation of 2,2,-bis-hydroxymethyl-butanediol-(1,4)
IL104477A0 (en) Process for preparing 4,6-dialkoxy-pyrimidines
EP0413661A3 (en) Process for preparing tris (2,4-di-tert-butyl-phenyl) phosphite
CS389491A3 (en) Process for preparing 4-substituted 2,6-dialkylanilines
CS659990A3 (en) Process for preparing crystalline 3,4-dimethyl-phenyl-n-d-ribitylamine
HU911705D0 (en) Process for producing 2,3-dichlorine-6-nitro-benzonitryl
HU911706D0 (en) Process for producing 2,3-dichlorine-6-amino-benzol derivatives
CS688090A3 (en) Process for preparing 1,2,3,-trichloro-4-nitrobenzene
CS259690A3 (en) Process for preparing 1,1,3-trimethyl-3-phenylindane
YU17689A (en) Process for obtaining 3,18-dihydroxy-9,13-epoxylabdan derivatives
CS365690A3 (en) Process for preparing 2-amino-4-chloro-6-methyl-1,3,5-triazine
CS301390A3 (en) Process for preparing crystalline 3,5,6-tri-o-benzyl-alpha-d-glucofuranose
CS365790A3 (en) Process for preparing n,n'-bis(2-chloro-4-aminophenyl) terephthaldiamide
YU35190A (en) Process for obtaining 2,4-bis(1,2,3,4-tetrahydronaphtyl-1- and 1,2,3,4-tetrahydronaphtyl-2-amino) -6-chlorine-s-triazine
HU208016B (en) Process for producing 15,20-anhydrovinblastin-borane-complex
CS302690A3 (en) Process for preparing 2,2-diphenyl-4-piperidine butanenitrile